In this presentation, USP and Eurofins Microbiology provide an overview of USP microbiology methods tests for microbial contamination in dietary supplements, CBD/hemp products, and probiotics. The session includes an in-depth discussion regarding the importance of suitability testing, and a comparison of USP methodology to AOAC/FDA BAM methodology. USP will also provide an update on new USP chapters and share insight on what is on the horizon for USP methods.
USP – Kit Goldman – Director, Dietary Supplements and Herbal Medicines
Eurofins Microbiology– Shannon Jacoby-Business Unit Manager and David Roth-Senior Client Services Manager
This webinar originally aired on Wednesday, November 18, 2020.